Meeting
2016 ASCO Annual Meeting
Phase I study of the PI3K/mTOR inhibitor gedatolisib (PF-05212384) in combination with docetaxel, cisplatin, and dacomitinib.
Authors
Zev A. Wainberg
Department of Medicine, University of California, Los Angeles, CA
Zev A. Wainberg , Geoffrey Shapiro , Giuseppe Curigliano , Rebecca Sophie Kristeleit , Stephen Leong , Maria Alsina , Michele Milella , Carolyn D. Britten , Karen A. Gelmon , Anthony J. Olszanski , Ulka N. Vaishampayan , Jose A. Lopez-Martin , Kenneth Alan Kern , Kristen J. Pierce , Rachelle Perea , Brett Houk , Nuzhat Pathan , Albiruni R. Razak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Pharmacology
Clinical Trial Registration Number
NCT01920061
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2566)
DOI
10.1200/JCO.2016.34.15_suppl.2566
Abstract #
2566
Poster Bd #
266
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Phase I study of the PI3K/mTOR inhibitor PF-05212384 in combination with other antitumor agents.
First Author: Zev A. Wainberg
Poster
2017 ASCO Annual Meeting
Safety and tolerability of the dual PI3K/mTOR inhibitor LY3023414 in combination with fulvestrant in treatment refractory advanced breast cancer patients.
First Author: Anna M. Varghese
Poster
2015 ASCO Annual Meeting
A phase I study of temsirolimus plus erlotinib in patients with refractory solid tumors.
First Author: Andrea Wang-Gillam
Poster
2023 ASCO Annual Meeting
A first-in-human, open label, multiple dose, dose escalation, and cohort expansion phase I study to investigate the safety, tolerability, pharmacokinetics and antitumor activity of BB-1701 in patients with locally advanced/metastatic HER2-expressing solid tumors.
First Author: Fei Ma